Copyright © 2001 by the European Society of Cardiology.
Editorials
The sirolimus coated stent: will the Achilles heel of interventional cardiology finally be cured?
The Division of Invasive Cardiology, Rambam Medical Center, Haifa, Israel
The Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel
References
- Teirstein PS, Massullo V, Jani S. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med. 1997;336:16971703
[Abstract/Free Full Text] - Costa MA, Sabate M, van der Giessen WJ. Late coronary occlusion after intracoronary brachytherapy. Circulation. 1999;100:789792
[Abstract/Free Full Text] - Topol EJ, Serruys PW. Frontiers in interventional cardiology. Circulation. 1998;98:18021820
[Free Full Text] - Sehgal SN, Baker H, Vezina C. Rapamycin (AY-22, 989) a new antifungal antibiotic. II. Fermentation, isolation and characterization. J Antibiot (Tokyo). 1975;28:727735[Medline]
- Groth CG, Backman L, Morales JM. Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. Transplantation. 1999;67:10361042[ISI][Medline]
- Chen D, Krasinki K, Chen D. Down-regulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in VSMC by p27, an inhibitor of neointima formation in the rat carotid artery. J Clin Invest. 1997;99:23342341[ISI][Medline]
- Hidalgo M, Rowinsky EK. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene. 2000;19:66806686[CrossRef][ISI][Medline]
- Braun-Dullaeus RC, Mann MJ, Seay U. Cell cycle protein in expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin. Arterioscler Thromb. 2001;21:11521159
[Abstract/Free Full Text] - Gallo R, Padurean A, Jayaraman T. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation. 1999;99:21642170
[Abstract/Free Full Text] - Burke SE, Lubbers NL, Chen YW. Neointimal formation after balloon-induced vascular injury in Yucatan minipigs is reduced by oral rapamycin. J Cardiovasc Pharmacol. 1999;33:829835[CrossRef][ISI][Medline]
- Sousa JE, Costa MA, Abizaid A. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation. 2001;103:192195
[Abstract/Free Full Text] - Abizaid A, Dangas G, Costa M. Sirolimus-coated stent prevents neointimal proliferation. Curr Interv Cardiol Rep. 2001;3:14[Medline]
- Rensing BJ, Vos J, Smits PC. Coronary restenosis elimination with a sirolimus eluting stent. First European human experience with 6-month angiographic and intravascular ultrasonic follow-up. Eur Heart J. 2001;22:21252130
[Abstract/Free Full Text] - Circulation. 1999;100:799806
[Abstract/Free Full Text]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||